Published in Thorax on July 01, 2004
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy. Br J Pharmacol (2009) 1.08
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.06
Transforming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2. Am J Respir Cell Mol Biol (2012) 0.90
Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features. Clin Transl Allergy (2012) 0.87
Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am J Respir Cell Mol Biol (2015) 0.87
Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Clin Exp Allergy (2008) 0.86
Expression of ADAMs and their inhibitors in sputum from patients with asthma. Mol Med (2006) 0.85
Allergen-induced coexpression of bFGF and TGF-β1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-β1 expression in vitro. Int Arch Allergy Immunol (2010) 0.83
Selectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix. Open Biol (2016) 0.76
Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed. J Immunol Res (2015) 0.75
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer. Oncotarget (2016) 0.75
Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma. PLoS One (2017) 0.75
Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol (1975) 10.52
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61
Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J (1996) 2.59
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry (1989) 2.49
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell (1994) 2.23
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol (2001) 2.12
The ins and outs of fibroblast growth factors. Cell (1994) 1.95
The elusive functions of proteoglycans: in vivo veritas. J Cell Biol (2000) 1.84
Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem (1993) 1.79
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med (1998) 1.76
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest (1997) 1.75
Expression of basic fibroblast growth factor in normal human tissues. Lab Invest (1990) 1.70
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis (1991) 1.49
Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry (2000) 1.47
Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol (1989) 1.42
Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol (2001) 1.13
Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood (1993) 1.06
Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen. Am J Respir Cell Mol Biol (1993) 1.04
Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol (2002) 1.03
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax (1999) 1.02
Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate. J Biol Chem (1999) 0.97
Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation. Gut (1996) 0.96
Human leucocyte heparan sulphate proteoglycans and their roles in inflammation. Biochem Soc Trans (1997) 0.83
Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages. Heart Vessels (1987) 0.78
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2000) 13.13
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res (1999) 5.41
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology (2008) 2.85
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax (2005) 2.39
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol (2000) 2.24
Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax (1984) 2.20
Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res (1999) 2.03
Interleukin 4 is localized to and released by human mast cells. J Exp Med (1992) 2.00
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol (1996) 1.87
Investigation and management of chronic cough using a probability-based algorithm. Eur Respir J (2005) 1.82
Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem (1993) 1.79
Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol (1993) 1.78
What's new about hay fever? Br Med J (Clin Res Ed) (1985) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) (1984) 1.73
Airway wall remodelling in asthma. Thorax (1997) 1.65
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1997) 1.64
Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet (1991) 1.59
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis (1991) 1.49
Bronchial sleeve resection with complete preservation of the lung for carcinoma. Respiration (2001) 1.44
Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol (1984) 1.44
Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res (1996) 1.33
BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy (2008) 1.29
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis (1985) 1.25
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J (1992) 1.20
Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax (2000) 1.20
Expanding access to coronary artery bypass surgery: who stands to gain? Br Heart J (1995) 1.16
Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer (1998) 1.16
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol (2007) 1.15
Heterogeneity of human mast cells based on cytokine content. J Immunol (1995) 1.15
Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol (2001) 1.13
Distal myopathy with rimmed vacuoles: novel mutations in the GNE gene. Neurology (2002) 1.11
Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol (2001) 1.11
Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis (1992) 1.11
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med (1995) 1.10
Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) (1983) 1.09
The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy (1992) 1.09
Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J (2001) 1.08
Cellular fatty acid composition of Campylobacter pylori from primates and ferrets compared with those of other campylobacters. J Clin Microbiol (1989) 1.08
Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers. J Physiol (1991) 1.06
Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol (2001) 1.06
The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol (1992) 1.05
Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant. Neurology (2004) 1.05
Clinical and laboratory findings in cases of toxic mastitis in cows in Northern Ireland. Vet Rec (2000) 1.04
New insights into airway inflammation by endobronchial biopsy. Am Rev Respir Dis (1992) 1.02
Abnormal oesophageal motility in patients with chronic cough. Thorax (2003) 1.02
Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol (1996) 1.02
Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin Exp Allergy (2003) 1.02
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J (2007) 1.02
Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Respir J (1992) 1.01
Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand (1999) 1.01
Is choice of general practitioner important for patients having coronary artery investigations? Qual Health Care (1994) 1.01
Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy (1999) 1.01
Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med (1996) 1.01
Treatment of bronchial stricture due to endobronchial tuberculosis. World J Surg (1997) 1.01
Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity. Microbes Infect (2001) 1.00
Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey. Allergy (2014) 0.97
Isolation of Haemophilus somnus from bovine milk. Vet Rec (1989) 0.97
TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy (1995) 0.96
Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax (1996) 0.96
Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg (1991) 0.96
Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer. Chest (1990) 0.94
The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol (1986) 0.93
Role of a streptococcal antigen in the pathogenesis of acute poststreptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease. J Immunol (1992) 0.93
Exhaled nitric oxide; relationship to clinicophysiological markers of asthma severity. Respir Med (1998) 0.93
Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. Biochim Biophys Acta (1995) 0.92
Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med (1994) 0.92
Airway effects of local challenge with hypertonic saline in exercise-induced asthma. Am J Respir Crit Care Med (1994) 0.92
Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res (1991) 0.92
15-lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med (1995) 0.92
Osteopontin is expressed and functional in human eosinophils. Allergy (2009) 0.92
The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre. Eur J Surg Oncol (2004) 0.91
Psychiatric emergencies: the check effect revisited. J Health Soc Behav (1999) 0.91
Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest (1991) 0.91
Clinicopathological and biological assessment of lung cancers with pleural dissemination. Ann Thorac Surg (2000) 0.90
Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy (2009) 0.90